A multi-center phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401)
- Citation:
- J Clin Oncol vol 35 (15 suppl) 11007
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2794
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Bristol Myers Squibb
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Sandra P. D'Angelo Michelle R. Mahoney Brian Van Tine James Atkins Mohammed M Milhem William D. Tap Cristina A. Antonescu Priya U. Kumthekar Gary K. Schwartz Howard Streicher
- Networks:
- COLUMBIA, IA018, LAPS-IL036, LAPS-MN026, LAPS-MO011, LAPS-NY016, NC002
- Study
- Alliance-A091401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: